Technical Analysis for MXCT - Maxcyte Inc

Grade Last Price % Change Price Change
B 900.0 0.00% 0.00
MXCT closed unchanged on Friday, May 14, 2021, on 2.21 times normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Flat
Historical MXCT trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
50 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
50 DMA Support Bullish 0.90%
Crossed Above 50 DMA Bullish 0.00%
Fell Below 50 DMA Bearish 1.58%
50 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Crossed Above 50 DMA Bullish -0.22%
Older End-of-Day Signals for MXCT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Maxcyte Inc Description

MaxCyte, Inc. focuses on cell-based medicines. The Company's cell modification technology, Flow electroporation, is used for discovery, development and manufacture of small molecule, biologic and cell-based therapeutics. The Company's products include instruments, processing assemblies and insourcing services. Its instruments include systems, such as the MaxCyte STX, the MaxCyte VLX and the MaxCyte GT. The Company's MaxCyte GT Flow Transfection System, the MaxCyte STX Scalable Transfection System and the MaxCyte VLX Large Scale Transfection System enable the development and production of transfected cells for an array of applications. The Company offers a platform, which enables the engineering of a range of cells, including human primary cells. Its products are used in applications, including drug discovery, protein production and cell therapy. The Company offers messenger ribonucleic acid (mRNA) CAR T-cell based platform for immuno-oncology indications, including solid cancers.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Engineering Biotechnology Medicine Life Sciences Sourcing Cancer Branches Of Biology Oncology Mr Therapy Biology Drug Discovery Molecular Biology Cancers Cell Therapy Laboratory Techniques Gene Delivery

Is MXCT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News


Indicator Value
52 Week High 1060.0
52 Week Low 160.0
Average Volume 78,172
200-Day Moving Average 597.32
50-Day Moving Average 880.02
20-Day Moving Average 879.20
10-Day Moving Average 896.40
Average True Range 30.21
ADX 14.07
+DI 15.02
-DI 15.02
Chandelier Exit (Long, 3 ATRs ) 849.37
Chandelier Exit (Short, 3 ATRs ) 910.63
Upper Bollinger Band 930.40
Lower Bollinger Band 828.00
Percent B (%b) 0.7
BandWidth 11.65
MACD Line 7.79
MACD Signal Line 5.76
MACD Histogram 2.034
Fundamentals Value
Market Cap 694.44 Million
Num Shares 77.2 Million
EPS -25.40
Price-to-Earnings (P/E) Ratio -35.43
Price-to-Sales 13.72
Price-to-Book 11.54
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 945.00
Resistance 3 (R3) 943.33 926.67 937.50
Resistance 2 (R2) 926.67 915.21 927.50 935.00
Resistance 1 (R1) 913.33 908.13 905.00 915.00 932.50
Pivot Point 896.67 896.67 892.50 897.50 896.67
Support 1 (S1) 883.33 885.21 875.00 885.00 867.50
Support 2 (S2) 866.67 878.13 867.50 865.00
Support 3 (S3) 853.33 866.67 862.50
Support 4 (S4) 855.00